AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Natwest Group PLC

Transaction in Own Shares Mar 17, 2023

Preview not available for this file type.

Download Source File

author: Addison, Yvonne (Legal, Governance & Regulatory Affairs)
date: 2023-03-16 16:42:00+00:00


NatWest Group plc NatWest Group plc NatWest Group plc NatWest Group plc NatWest Group plc NatWest Group plc NatWest Group plc
16 March 2023 16 March 2023 16 March 2023 16 March 2023 16 March 2023 16 March 2023
Transaction in Own Shares Transaction in Own Shares Transaction in Own Shares Transaction in Own Shares Transaction in Own Shares Transaction in Own Shares Transaction in Own Shares
NatWest Group plc (the 'Company' or 'NWG') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS'). NatWest Group plc (the 'Company' or 'NWG') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS'). NatWest Group plc (the 'Company' or 'NWG') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS'). NatWest Group plc (the 'Company' or 'NWG') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS'). NatWest Group plc (the 'Company' or 'NWG') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS'). NatWest Group plc (the 'Company' or 'NWG') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS').
Aggregated information: Aggregated information:
Date of purchase Number of Ordinary Shares purchased Highest price paid: (GBp) Lowest price paid: (GBp) Volume weighted average price paid per share (GBp) Venue
16 March 2023 4,233,742 263.40 256.90 260.4031 LSE
16 March 2023 1,847,120 263.40 257.00 260.3785 CHIX
16 March 2023 3,755,891 263.40 256.80 260.3810 BATE
* Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share * Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share * Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share * Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share * Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share * Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share
Such purchases form part of the Company’s existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 17 February 2023, as announced on 17 February 2023. Such purchases form part of the Company’s existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 17 February 2023, as announced on 17 February 2023. Such purchases form part of the Company’s existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 17 February 2023, as announced on 17 February 2023. Such purchases form part of the Company’s existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 17 February 2023, as announced on 17 February 2023. Such purchases form part of the Company’s existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 17 February 2023, as announced on 17 February 2023. Such purchases form part of the Company’s existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 17 February 2023, as announced on 17 February 2023.
The Company intends to cancel the repurchased Ordinary Shares. The Company intends to cancel the repurchased Ordinary Shares. The Company intends to cancel the repurchased Ordinary Shares. The Company intends to cancel the repurchased Ordinary Shares. The Company intends to cancel the repurchased Ordinary Shares. The Company intends to cancel the repurchased Ordinary Shares. The Company intends to cancel the repurchased Ordinary Shares.
Following the settlement of the above transactions, NWG will hold 85,910,882 Ordinary Shares in treasury and have 9,652,163,344 Ordinary Shares in issue (excluding treasury shares). Following the settlement of the above transactions, NWG will hold 85,910,882 Ordinary Shares in treasury and have 9,652,163,344 Ordinary Shares in issue (excluding treasury shares). Following the settlement of the above transactions, NWG will hold 85,910,882 Ordinary Shares in treasury and have 9,652,163,344 Ordinary Shares in issue (excluding treasury shares). Following the settlement of the above transactions, NWG will hold 85,910,882 Ordinary Shares in treasury and have 9,652,163,344 Ordinary Shares in issue (excluding treasury shares). Following the settlement of the above transactions, NWG will hold 85,910,882 Ordinary Shares in treasury and have 9,652,163,344 Ordinary Shares in issue (excluding treasury shares). Following the settlement of the above transactions, NWG will hold 85,910,882 Ordinary Shares in treasury and have 9,652,163,344 Ordinary Shares in issue (excluding treasury shares).
Further information: Further information: Further information: Further information: Further information: Further information: Further information:
Investor Relations
+ 44 (0)207 672 1758 + 44 (0)207 672 1758
Media Relations
+44 (0)131 523 4205 +44 (0)131 523 4205
Legal Entity Identifier: 2138005O9XJIJN4JPN90 Legal Entity Identifier: 2138005O9XJIJN4JPN90 Legal Entity Identifier: 2138005O9XJIJN4JPN90 Legal Entity Identifier: 2138005O9XJIJN4JPN90 Legal Entity Identifier: 2138005O9XJIJN4JPN90 Legal Entity Identifier: 2138005O9XJIJN4JPN90 Legal Entity Identifier: 2138005O9XJIJN4JPN90
Transaction details Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme is available here: [RNS team to insert link] In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme is available here: [RNS team to insert link] In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme is available here: [RNS team to insert link] In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme is available here: [RNS team to insert link] In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme is available here: [RNS team to insert link] In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme is available here: [RNS team to insert link]

Talk to a Data Expert

Have a question? We'll get back to you promptly.